Scleral Lens Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

Scleral Lens Market Overview

The global scleral lens market is witnessing steady growth, driven by the increasing prevalence of eye conditions such as keratoconus, irregular astigmatism, and dry eye syndrome. Scleral lenses are a specialized type of contact lens that provide comfort and improved vision for individuals with various corneal irregularities. These lenses are gaining popularity due to their ability to offer stable vision correction while minimizing discomfort for patients with complex ocular conditions.

Market Size

The scleral lens market is projected to grow at a compound annual growth rate (CAGR) of 5% to 7% during the forecast period. This growth is fueled by the growing demand for advanced vision correction solutions, rising awareness about scleral lenses, and improvements in lens technology that enhance comfort and durability.

Market Share & Trends Analysis

By Application

The scleral lens market is segmented by application into hospitals and eye clinics, where the adoption of scleral lenses is increasing due to their effectiveness in treating challenging corneal conditions.

• Hospitals: Scleral lenses are widely used in hospitals for patients with severe eye conditions or corneal irregularities. This segment is expected to grow at a CAGR of 4% to 6%, as hospitals continue to adopt more specialized ocular treatments.
• Eye Clinic: Eye clinics represent the largest segment in the scleral lens market, with growing demand from patients seeking effective vision correction options for conditions such as keratoconus. This segment is forecasted to grow at a CAGR of 6% to 8%, driven by an increase in specialized vision care services and greater patient awareness.

By Product Type

The scleral lens market is segmented by product type into mini-scleral lenses and large-scleral lenses, both of which cater to different patient needs and corneal conditions.

• Mini-Scleral Lenses: Mini-scleral lenses are smaller than large-scleral lenses and are used primarily for treating mild to moderate corneal irregularities. This segment is expected to grow at a CAGR of 5% to 7%, as they provide a more comfortable and easier fit for a broader patient demographic.
• Large-Scleral Lenses: Large-scleral lenses, which are designed to cover a larger portion of the cornea, are used for more severe cases of corneal irregularities and dry eye syndrome. This segment is anticipated to grow at a CAGR of 7% to 9%, as they provide superior vision correction and increased comfort for patients with more complex eye conditions.

Key Players

Key players in the scleral lens market include:

• ABB Optical: A leading supplier of optical products, including a wide range of scleral lenses for patients with irregular corneas.
• Bausch Health: Bausch Health offers a variety of eye care solutions, including scleral lenses designed to address specific patient needs in vision correction.
• Visionary Optics: Known for their innovative scleral lens designs, Visionary Optics plays a significant role in the advancement of customized lenses for challenging eye conditions.
• Essilor: Essilor provides a wide range of vision correction products, including scleral lenses that are widely used for treating various ocular conditions.
• Art Optical: Art Optical specializes in custom scleral lenses and other specialty contact lenses for treating corneal irregularities.
• CooperVision: CooperVision offers a broad portfolio of specialty lenses, including scleral lenses, for patients with complex vision needs.
• BostonSight: BostonSight focuses on providing customized scleral lenses for patients with advanced corneal disease, offering both mini and large-scleral lens options.
• AccuLens: AccuLens is a well-regarded manufacturer of scleral lenses, offering both mini and large variants to address various ocular conditions.
• Tru-Form Optics: Known for producing high-quality custom scleral lenses, Tru-Form Optics is a key player in the growing market for specialized contact lenses.
• Advanced Vision Technologies: A leader in specialty contact lenses, Advanced Vision Technologies produces scleral lenses to provide optimal vision for patients with irregular corneas.
• Valley Contax: Valley Contax offers a range of contact lenses, including scleral lenses for the treatment of advanced corneal conditions.
• Capricornia: Capricornia manufactures custom-designed scleral lenses for various corneal conditions, playing an essential role in the market for specialty lenses.
• Menicon: Menicon is a major player in the scleral lens market, providing high-quality lenses for patients with complex vision requirements.

By Region

The scleral lens market is expected to grow across key regions, including North America, Europe, Asia-Pacific, and the rest of the world.

• North America: North America is anticipated to hold a significant market share, with an estimated share of 35% to 40%, growing at a CAGR of 5% to 7%. This growth is driven by a high prevalence of eye conditions and increased access to specialized vision care in the region.
• Europe: Europe is expected to grow at a CAGR of 4% to 6%, with a market share of 25% to 30%, due to rising demand for advanced vision correction solutions and an increasing number of specialized eye care clinics.
• Asia-Pacific: The Asia-Pacific region is projected to experience the highest growth rate, with a CAGR of 7% to 9% and a market share of 20% to 25%, driven by increasing healthcare access and a growing aging population.
• Rest of the World: The rest of the world, including regions such as Latin America and the Middle East, is expected to grow at a CAGR of 4% to 6%, as access to advanced eye care technologies increases in emerging markets.

Segment Forecasts (2025-2030)

Growth in Key Segments

• Mini-Scleral Lenses: The mini-scleral lens segment is expected to grow at a CAGR of 5% to 7% as more patients seek comfort and efficacy in lenses designed for moderate corneal irregularities.
• Large-Scleral Lenses: Large-scleral lenses will likely see significant growth, with a CAGR of 7% to 9%, driven by their effectiveness in treating severe corneal irregularities and conditions such as dry eye syndrome.